Northwestern Mutual Wealth Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $360K | Sell |
3,474
-37
| -1% | -$3.91K | ﹤0.01% | 1682 |
|
|
2025
Q4 | $367K | Buy |
3,511
+720
| +26% | +$72.4K | ﹤0.01% | 1649 |
|
|
2025
Q3 | $258K | Buy |
2,791
+150
| +6% | +$13.1K | ﹤0.01% | 1697 |
|
|
2025
Q2 | $211K | Sell |
2,641
-615
| -19% | -$49.1K | ﹤0.01% | 1722 |
|
|
2025
Q1 | $282K | Sell |
3,256
-338
| -9% | -$28.8K | ﹤0.01% | 1530 |
|
|
2024
Q4 | $297K | Sell |
3,594
-2,424
| -40% | -$209K | ﹤0.01% | 1499 |
|
|
2024
Q3 | $523K | Sell |
6,018
-808
| -12% | -$69.1K | ﹤0.01% | 1283 |
|
|
2024
Q2 | $561K | Buy |
6,826
+2,266
| +50% | +$180K | ﹤0.01% | 1216 |
|
|
2024
Q1 | $366K | Sell |
4,560
-48
| -1% | -$3.72K | ﹤0.01% | 1338 |
|
|
2023
Q4 | $351K | Sell |
4,608
-1,201
| -21% | -$85.9K | ﹤0.01% | 1315 |
|
|
2023
Q3 | $420K | Buy |
5,809
+63
| +1% | +$4.83K | ﹤0.01% | 1220 |
|
|
2023
Q2 | $435K | Sell |
5,746
-173
| -3% | -$13.2K | ﹤0.01% | 1200 |
|
|
2023
Q1 | $450K | Sell |
5,919
-248
| -4% | -$19.1K | ﹤0.01% | 1164 |
|
|
2022
Q4 | $485K | Sell |
6,167
-2,194
| -26% | -$169K | ﹤0.01% | 1104 |
|
|
2022
Q3 | $596K | Sell |
8,361
-481
| -5% | -$35.9K | ﹤0.01% | 976 |
|
|
2022
Q2 | $663K | Sell |
8,842
-2,606
| -23% | -$198K | ﹤0.01% | 945 |
|
|
2022
Q1 | $911K | Sell |
11,448
-2,046
| -15% | -$159K | ﹤0.01% | 879 |
|
|
2021
Q4 | $1.09M | Buy |
13,494
+2,367
| +21% | +$187K | ﹤0.01% | 795 |
|
|
2021
Q3 | $861K | Sell |
11,127
-361
| -3% | -$29.1K | ﹤0.01% | 804 |
|
|
2021
Q2 | $924K | Sell |
11,488
-1,446
| -11% | -$115K | ﹤0.01% | 784 |
|
|
2021
Q1 | $1.02M | Hold |
12,934
| – | – | ﹤0.01% | 696 |
|
|
2020
Q4 | $923K | Buy |
12,934
+8,026
| +164% | +$537K | ﹤0.01% | 664 |
|
|
2020
Q3 | $313K | Buy |
4,908
+1,386
| +39% | +$90.6K | ﹤0.01% | 885 |
|
|
2020
Q2 | $228K | Buy |
3,522
+3,083
| +702% | +$192K | ﹤0.01% | 921 |
|
|
2020
Q1 | $24K | Hold |
439
| – | – | ﹤0.01% | 1638 |
|
|
2019
Q4 | $28K | Hold |
439
| – | – | ﹤0.01% | 1643 |
|
|
2019
Q3 | $25K | Hold |
439
| – | – | ﹤0.01% | 1661 |
|
|
2019
Q2 | $26K | Sell |
439
-1,043
| -70% | -$64K | ﹤0.01% | 1630 |
|
|
2019
Q1 | $96K | Buy |
1,482
+799
| +117% | +$52.5K | ﹤0.01% | 1120 |
|
|
2018
Q4 | $42K | Buy |
683
+583
| +583% | +$39.3K | ﹤0.01% | 1321 |
|
|
2018
Q3 | $7K | Hold |
100
| – | – | ﹤0.01% | 2035 |
|
|
2018
Q2 | $7K | Buy |
+100
| New | +$6.43K | ﹤0.01% | 1940 |
|
|
2017
Q4 | – | Sell |
-48
| Closed | -$3K | – | 2416 |
|
|
2017
Q3 | $3K | Hold |
48
| – | – | ﹤0.01% | 1927 |
|
|
2017
Q2 | $3K | Buy |
+48
| New | +$2.88K | ﹤0.01% | 1837 |
|
|
2016
Q1 | – | Sell |
-179
| Closed | -$13K | – | 2250 |
|
|
2015
Q4 | $13K | Buy |
+179
| New | +$12.7K | ﹤0.01% | 1123 |
|
|
2014
Q2 | – | Sell |
-400
| Closed | -$23K | – | 1362 |
|
|
2014
Q1 | $23K | Buy |
+400
| New | +$22.7K | ﹤0.01% | 738 |
|
|
2013
Q3 | – | Sell |
-33
| Closed | -$1K | – | 1455 |
|
|
2013
Q2 | $1K | Buy |
+33
| New | +$1.37K | ﹤0.01% | 1194 |
|
Other funds holding PJP
PAM
CI
Northwestern Mutual Wealth Management's PJP Position: Q1 2026 in Review
Northwestern Mutual Wealth Management reduced its Invesco Pharmaceuticals ETF (PJP) stake by 1.1% in Q1 2026, selling an estimated $3.91K and leaving 3,474 shares worth $360K. The position accounts for ﹤0.01% of the portfolio, ranked #1682.
Northwestern Mutual Wealth Management first reported a position in PJP in Q2 2013 and has held it in 37 quarters since. The position peaked at $1.09M in Q4 2021. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.
- Northwestern Mutual Wealth Management held 3,474 shares of Invesco Pharmaceuticals ETF worth $360K as of Q1 2026.
- Northwestern Mutual Wealth Management sold 37 Invesco Pharmaceuticals ETF shares in Q1 2026, an estimated $3.91K.
- Invesco Pharmaceuticals ETF made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #1682 holding.
- Northwestern Mutual Wealth Management first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and has held it in 37 quarters since.
- Northwestern Mutual Wealth Management's Invesco Pharmaceuticals ETF position peaked at $1.09M in Q4 2021.
- 119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.